Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval By Sam | August 20, 2020 Mylan has launched the product in 120mg and 240mg delayed-release capsule forms. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter